This inventor holds 1 USPTO granted patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Albert Zendman: Innovator in Tumor Sample Analysis
Introduction
Albert Zendman is a notable inventor based in Beuningen, Netherlands. He has made significant contributions to the field of medical diagnostics, particularly in the analysis of tumor samples. His innovative work has the potential to impact cancer treatment and patient outcomes.
Latest Patents
Albert Zendman holds a patent for a process titled "Process for the determination of CTp11 and for determining whether a tumor sample has metastatic potential." This patent outlines a method for assessing the metastatic potential of tumor samples, which is crucial for determining appropriate treatment strategies for cancer patients. The patent reflects his commitment to advancing medical technology and improving diagnostic accuracy.
Career Highlights
Throughout his career, Albert has been associated with Hoffmann-La Roche Inc., a leading global healthcare company. His work at this esteemed organization has allowed him to collaborate with other experts in the field and contribute to groundbreaking research in oncology.
Collaborations
One of his notable collaborators is Goos Van Muijen. Together, they have worked on various projects aimed at enhancing the understanding of tumor biology and improving diagnostic methods.
Conclusion
Albert Zendman's contributions to the field of medical diagnostics, particularly through his patent on tumor sample analysis, highlight his role as an innovator in cancer research. His work continues to pave the way for advancements in the diagnosis and treatment of cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile